BZ
Next earnings: May 28, 2026 · Before open
Signal
Leaning Bearish1
Price
1
Move+0.96%Quiet session
Volume
1
Volume0.5× avgLight volume
Technical
1
RSIRSI 43Momentum negative
PRICE
Prev Close
13.52
Open
13.82
Day Range13.44 – 13.87
13.44
13.87
52W Range12.85 – 25.26
12.85
25.26
6% of range
VOLUME & SIZE
Avg Volume
4.2M
FUNDAMENTALS
P/E Ratio
15.9x
EPS (TTM)
Div Yield
No dividend
Beta
1.61
High vol
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +12% YoY · 85% gross margin
Valuation
FAIR
P/E 16x vs ~20x sector
Health
STRONG
CR 4.7 · FCF $7.17/sh
Strong Buy
Key MetricsTTM
Market Cap$43.15B
Revenue TTM$8.24B
Net Income TTM$2.73B
Free Cash Flow$3.33B
Gross Margin85.1%
Net Margin33.1%
Operating Margin30.2%
Return on Equity15.2%
Return on Assets11.1%
Debt / Equity0.01
Current Ratio4.66
EPS TTM$5.87

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong2 watch1 concern
57/100
Liquidity
4.66Strong
Leverage
0.01Strong
Coverage
0.0xConcern
ROE
15.2%Strong
ROIC
10.3%Watch
Cash
$4.1BWatch
ANALYST COVERAGE9 analysts
BUY
+105.1%upside to target
Buy
889%
Hold
111%
8 Buy (89%)1 Hold (11%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
5/10
Technicals
RSI RangeRSI 43 — Bearish momentum
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 4.66 — healthy liquidity

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · After CloseMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 10, 2026
In 99 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 26.1%

-5.2% vs SMA 50 · -30.0% vs SMA 200

Momentum

RSI42.5
Momentum fading
MACD-0.93
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$25.26+85.1%
EMA 200
$18.44+35.1%
EMA 50
$15.99+17.1%
Current
$13.65
52W Low
$12.85-5.9%
52-Week RangeNear 52-week low
$12.856th %ile$25.26
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 14 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$7.3B
$7.1B$7.6B
$5.94
±4%
High11
FY2025
$8.3B
$8.0B$8.6B
+12.5%$7.72+30.0%
±5%
High14
FY2026(current)
$9.4B
$9.1B$9.6B
+13.6%$8.51+10.3%
±3%
High13
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryBZ
Last 8Q
+6.3%avg beat
Beat 6 of 8 quartersMissed 1 Estimates rising
+23%
Q2'24
+10%
Q3'24
+10%
Q4'24
+5%
Q1'25
+9%
Q2'25
+4%
Q3'25
Q4'25
-10%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Itau BBAMarket Perform → Outperform
Jan 27
UPGRADE
Goldman SachsBuy
Jan 21
UPGRADE
ScotiabankSector Perform → Outperform
Dec 4
UPGRADE
Morgan StanleyOverweight → Neutral
Nov 5
UPGRADE
Morgan StanleyOverweight → Underweight
Nov 5
DOWNGRADE
SantanderNeutral → Overweight
Nov 25
UPGRADE
CitigroupBuy
Nov 18
UPGRADE
UBSBuy → Sell
Nov 11
DOWNGRADE
UBSSell → Buy
Sep 18
UPGRADE
UBSNeutral → Buy
Aug 8
UPGRADE
DaiwaNeutral
Jul 25
DOWNGRADE
CitigroupCautious → Buy
Jul 5
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Mu YangDir
$114K
Mar 30
SELL
Wang WenbeiCFO
$5K
Mar 30
SELL
Mu YangDir
$3K
Mar 20
SELL
Wang XiehuaDir
$777
Mar 20
SELL
Wang WenbeiCFO
$134
Mar 20
SELL
Zhao Peng JonathanCEO
$447K
Mar 18
SELL
Financials
Dividends1.23% yield
2 yrs of payments
Annual Yield1.23%
Annual Div.$0.1680
Est. Annual / Share$0.17
FrequencyAnnual
Q4'23
Q4'25

Dividend per payment — last 2 periods

INSTITUTIONAL OWNERSHIP

1
Robeco Institutional Asset Management B.V.
9.6M
2
Assenagon Asset Management S.A.
4.2M
3
Sumitomo Mitsui Trust Holdings, Inc.
2.9M
4
RWC ASSET ADVISORS (US) LLC
2.9M
5
E Fund Management Co., Ltd.
1.7M
6
HSBC HOLDINGS PLC
1.7M
7
RWC Asset Management LLP
856K
8
Nuveen, LLC
725K
News & Activity

BZ News

20 articles · 4h ago

About

No description available.

Wenbei WangVP, Deputy CFO and Head of Investor Relations & Capital Markets
Xu ChenPresident & Executive Director
Xiehua WangVice President of Product & Executive Director